BioMarin Pharmaceutical Market Cap

BioMarin Pharmaceutical has a market cap or net worth of €9.81 billion as of December 24, 2025. Its market cap has decreased by -18.45% in one year.

Market Cap

9.81B

Enterprise Value

9.07B

Revenue

2.64B

Ranking

n/a

PE Ratio

22.13

Stock Price

€51.48

Market Cap Chart

Since July 23, 1999, BioMarin Pharmaceutical's market cap has increased from 425.62M to 9.81B, an increase of 2,205.98%. That is a compound annual growth rate of 12.60%.

Market Cap History

Date	Market Cap	% Change
Dec 24, 2025	9.81B	-18.89%
Dec 31, 2024	12.10B	-26.36%
Dec 29, 2023	16.43B	-8.70%
Dec 30, 2022	18.00B	26.18%
Dec 31, 2021	14.26B	9.60%
Dec 31, 2020	13.01B	-3.84%
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro
Dec 31, 2015	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Erste Group Bank AG	39.26B
VERBUND AG	21.42B
OMV Aktiengesellschaft	15.34B
Raiffeisen Bank International AG	12.37B
BAWAG Group AG	9.70B
Strabag SE	9.20B
Vienna Insurance Group AG	8.45B
Andritz AG	6.44B

Market Cap Rankings